Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2001-07-23

Original market date: See footnote 1

1999-12-15

Product name:

U.G.I.T.

DIN:

02239313 Electronic product monograph is not available

Company:

MORINDA CANADA
UNIT 1 6600 Dixie Road
Mississauga
Ontario
Canada L5T 2Y2

Class:

Human

Dosage form(s):

Capsule

Route(s) of administration:

Oral

Number of active ingredient(s):

13

Schedule(s):

OTC

 

American Hospital Formulary Service (AHFS): See footnote 3

88:28.01* See footnote6 

Anatomical Therapeutic Chemical (ATC): See footnote 4

A11JB VITAMINS WITH MINERALS

Active ingredient group (AIG) number:See footnote5

1335562001

List of active ingredient(s)
Active ingredient(s) Strength
BETA-CAROTENE (PROVITAMIN A) 1250 UNIT / CAP
CHROMIUM (CHROMIUM HVP CHELATE) 72 MCG / CAP
FOLIC ACID 0.4 MG / CAP
MANGANESE (MANGANESE HVP CHELATE) 0.05 MG / CAP
MOLYBDENUM (MOLYBDENUM HVP CHELATE) 13 MCG / CAP
POTASSIUM (POTASSIUM HVP CHELATE) 1.25 MG / CAP
SELENIUM (SELENIUM HVP CHELATE) 28 MCG / CAP
SILICON (SILICON HVP CHELATE) 0.03 MG / CAP
VANADIUM (VANADIUM HVP CHELATE) 3 MCG / CAP
VITAMIN B12 25 MCG / CAP
VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE, PYRIDOXAL-5-PHOSPHATE) 23 MG / CAP
VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 80 UNIT / CAP
ZINC (ZINC HVP CHELATE) 0.4 MG / CAP
Version 4.0.2
Date modified: